Makers Lab Peer Comparison

BSE: 506919

₹190.37

₹-0.51 (-0.27%)

As on 21-Sep-2026IST

Market cap

₹112 Cr

Revenue (TTM)

₹148 Cr

P/E Ratio

32.6

P/B Ratio

1.4

Div. Yield

0 %

Edit

	Makers Lab	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Market cap (₹ Cr)	112	20,956	20,944	17,950	18,477
Revenue (₹ Cr)	148	2,287	1,682	3,230	2,570
Net Profit (₹ Cr)	11.17	678.07	273.51	666.92	735.15
Net Margin (%)	7.43	28.10	16.19	20.60	26.88
RoE (%)	4.76	19.73	11.15	18.75	19.16
Price to Earnings	32.62	31.50	70.44	27.88	25.13
Price-To-Book	1.44	5.71	7.80	4.45	4.19

Income Statement (₹ Cr)

	Makers Lab	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Operating Revenue	148.37	2,287.33	1,682.47	3,229.67	2,569.77
Total Income	150.42	2,413.29	1,689.83	3,237.12	2,735.39
Total Expenditure	129.68	1,490.75	1,203.91	2,090.06	1,628.14
EBITDA	18.69	796.58	478.55	1,139.61	941.63
Depreciation	4.54	78.10	126.01	281.06	57.58
EBIT	14.15	718.48	352.55	858.55	884.05
Interest	0.74	0.88	52.11	190.64	7.69
Other Income	2.05	125.96	7.37	7.45	165.62
Exceptional Items	0.00	0.00	12.16	-17.24	-49.16
Profit before Tax	15.47	843.56	319.96	658.12	992.82
Provision for Tax	4.30	165.49	46.45	-8.80	257.67
Profit after Tax	11.17	678.07	273.51	666.92	735.15

	Makers Lab	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Shareholder's Funds	72.92	3,586.42	2,591.20	3,902.67	4,202.90
Minority Interest	-7.75	-12.71	0.00	-21.81	0.00
Non-Current Liabilities	10.12	28.74	266.35	1,392.75	91.50
Current Liabilities	34.02	385.94	848.06	2,077.10	627.48
Total Liabilities	166.62	4,037.51	3,705.61	7,246.72	4,921.88

	Makers Lab	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Non-Current Assets	73.14	1,291.22	2,525.44	5,617.77	770.28
Current Assets	86.95	2,585.66	1,109.77	1,539.85	3,803.22
Total Assets	166.62	4,037.51	3,705.61	7,246.72	4,921.88
Total Debt*	4.76	0.57	657.97	2,309.68	2.50
Net Current Assets	52.93	2,199.72	261.71	-537.25	3,175.74
Contingent Liabilities	4.71	17.53	160.01	51.57	370.49

	Makers Lab	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Cash From Operating Activities	14.29	523.24	342.18	537.99	967.57
Cash Flow from Investing Activities	-14.69	-582.30	-325.92	-369.46	-561.67
Cash from Financing Activities	0.35	-46.46	13.62	-313.53	-798.31
Net Cash Inflow / Outflow	-0.05	-105.52	29.88	-145.00	-392.41

	Makers Lab	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
ROCE (%)	15.83	24.97	11.43	14.47	23.39
ROE (%)	4.76	19.73	11.15	18.75	19.16
ROA (%)	7.10	18.69	7.80	9.26	14.95
EBIT Margin (%)	9.54	31.41	20.95	26.58	34.40
Net Margin (%)	7.43	28.10	16.19	20.60	26.88
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

	Makers Lab	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Revenue Growth (%)	17.60	15.01	27.91	9.59	10.69
EBIT Growth (%)	185.19	18.45	58.32	16.84	24.14
Net Profit Growth (%)	-13.38	19.61	149.56	62.68	-9.09
EPS Growth (%)	-61.24	17.73	-3.57	67.41	14.40
Book Value Growth (%)	3.43	26.75	9.67	36.71	-0.34

	Makers Lab	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Price / Earnings	32.64	31.50	74.73	27.20	23.95
Price / Book Value	1.44	5.71	7.80	4.45	4.19
Dividend Yield (%)	0.00	0.29	0.06	0.00	1.86
EV/EBITDA	5.57	25.04	45.05	17.72	16.32
Market Cap (₹ Cr)	79.77	11,439.22	6,819.66	17,980.08	21,592.90

	Makers Lab	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Debt to Equity	0.01	0.00	0.07	0.24	0.00
Short term debt to equity ratio	0.04	0.00	0.16	0.12	0.00
Current Ratio	2.56	6.70	1.31	0.74	6.06
Quick Ratio	1.23	5.59	0.88	0.53	5.31
Interest Coverage	21.93	959.59	7.14	4.45	130.11

	Makers Lab	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Debtors to sales (%)	13.39	36.10	30.84	21.07	7.07
Asset Turnover	0.94	0.63	0.48	0.45	0.52
Receivable days	62.18	121.68	113.81	63.88	26.06
Inventory Days	102.52	63.83	84.76	43.27	65.95
Payable days	90.08	108.28	101.94	151.85	81.01
Cash Conversion Cycle	74.62	77.23	96.62	-44.70	11.00

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.